Shigeto Yamawaki Selected Research

Length of Stay

1/2018	Predictors of negative symptoms in the chronic phase of schizophrenia: A cross-sectional study.
5/2012	Predictors of quality of life in inpatients with schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shigeto Yamawaki Research Topics

Disease

11	Schizophrenia (Dementia Praecox) 06/2020 - 01/2002
10	Major Depressive Disorder (Major Depressive Disorders) 10/2020 - 10/2006
5	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 09/2013 - 06/2005
5	Neoplasms (Cancer) 10/2011 - 11/2002
4	Mental Disorders (Mental Disorder) 01/2020 - 06/2005
4	Inflammation (Inflammations) 01/2020 - 01/2016
4	Mood Disorders (Mood Disorder) 01/2016 - 02/2002
3	Stroke (Strokes) 04/2021 - 10/2007
3	Dementia (Dementias) 11/2013 - 01/2004
2	Pain (Aches) 01/2021 - 12/2015
2	Neuroinflammatory Diseases 01/2021 - 01/2020
2	Psychotic Disorders (Schizoaffective Disorder) 06/2020 - 06/2016
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019 - 06/2015
2	Dyskinesias (Dyskinesia) 01/2018 - 05/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 11/2013 - 10/2011
2	Bipolar Disorder (Manic Depressive Psychosis) 03/2013 - 10/2006
2	Hyperprolactinemia 12/2012 - 11/2004
1	Anxiety Disorders (Anxiety Disorder) 08/2023
1	Drug Resistant Epilepsy 08/2022
1	Endotoxemia 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2020
1	Tardive Dyskinesia 06/2020
1	Brain Injuries (Brain Injury) 01/2020
1	Anorexia 12/2019
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 07/2019
1	Alcoholism (Alcohol Abuse) 07/2019
1	Anhedonia 01/2019
1	Depressive Disorder (Melancholia) 01/2017
1	Mania (Manias) 06/2016
1	Treatment-Resistant Depressive Disorder 01/2016
1	Seizures (Absence Seizure) 03/2013
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2012
1	Panic Disorder (Panic Attack) 01/2012
1	Lung Neoplasms (Lung Cancer) 10/2011
1	Weight Gain 08/2008
1	Vascular Depression 04/2008
1	Glioma (Gliomas) 04/2007
1	Wounds and Injuries (Trauma) 12/2006

Drug/Important Bio-Agent (IBA)

10	Antidepressive Agents (Antidepressants)IBA 10/2020 - 02/2002
10	Antipsychotic Agents (Antipsychotics)IBA 06/2020 - 03/2002
4	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2002
4	Cholinergic Antagonists (Anticholinergics)IBA 01/2018 - 01/2002
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2019
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2013 - 04/2011
3	Risperidone (Risperdal Consta)FDA LinkGeneric 12/2012 - 03/2002
3	Olanzapine (Zyprexa)FDA Link 08/2008 - 11/2004
3	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 04/2007 - 03/2004
2	Escitalopram FDA Link 10/2020 - 04/2016
2	CytokinesIBA 12/2019 - 11/2002
2	LithiumIBA 01/2017 - 11/2002
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2017 - 03/2013
2	Histone Deacetylase InhibitorsIBA 01/2016 - 09/2013
2	Yi-Gan SanIBA 11/2013 - 10/2011
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2013 - 08/2008
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 09/2013 - 08/2006
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2012 - 01/2009
2	Serotonin (5 Hydroxytryptamine)IBA 01/2012 - 03/2004
2	Indicators and Reagents (Reagents)IBA 03/2011 - 11/2002
2	Paroxetine (Paxil)FDA LinkGeneric 01/2009 - 12/2006
2	Quetiapine Fumarate (Seroquel)FDA Link 11/2004 - 01/2004
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 04/2021
1	ONO-2952IBA 01/2020
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2020
1	Phosphotransferases (Kinase)IBA 12/2019
1	LipopolysaccharidesIBA 12/2019
1	Type C PhospholipasesIBA 12/2019
1	NF-kappa B (NF-kB)IBA 12/2019
1	lysophosphatidic acidIBA 01/2019
1	EnzymesIBA 01/2019
1	ImmunosorbentsIBA 01/2019
1	Histones (Histone)IBA 01/2018
1	CholesterolIBA 01/2018
1	Triglycerides (Triacylglycerol)IBA 01/2018
1	Uric Acid (Urate)IBA 01/2018
1	Tissue Inhibitor of Metalloproteinase-2IBA 01/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2016
1	Matrix Metalloproteinases (MMPs)IBA 01/2016
1	GABA-A Receptors (GABA(A) Receptor)IBA 06/2015
1	Hypnotics and Sedatives (Sedatives)IBA 06/2015
1	Histamine AgentsIBA 06/2015
1	N-Methylaspartate (NMDA)IBA 09/2013
1	Vorinostat FDA Link 09/2013
1	Aripiprazole (Abilify)FDA Link 12/2012
1	GlucocorticoidsIBA 01/2009
1	Cycloserine (Seromycin)FDA Link 08/2008
1	GhrelinIBA 08/2008
1	Hormones (Hormone)IBA 08/2008
1	Methylphenidate (Ritalin)FDA LinkGeneric 04/2008

Therapy/Procedure

2	Neurofeedback 08/2023 - 01/2020
2	Length of Stay 01/2018 - 05/2012
2	Renal Dialysis (Hemodialysis) 11/2013 - 10/2011
2	Therapeutics 03/2013 - 07/2004
1	Vagus Nerve Stimulation 08/2022
1	Blood Pressure Monitors 01/2021
1	Transplantation 07/2019
1	Liver Transplantation 07/2019
1	Drug Therapy (Chemotherapy) 01/2017
1	Aftercare (After-Treatment) 12/2015
1	Complementary Therapies (Alternative Medicine) 06/2015
1	Activities of Daily Living (ADL) 10/2007